Yuan Cui

423 total citations
12 papers, 328 citations indexed

About

Yuan Cui is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Yuan Cui has authored 12 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Yuan Cui's work include RNA modifications and cancer (5 papers), Ferroptosis and cancer prognosis (5 papers) and Ion channel regulation and function (4 papers). Yuan Cui is often cited by papers focused on RNA modifications and cancer (5 papers), Ferroptosis and cancer prognosis (5 papers) and Ion channel regulation and function (4 papers). Yuan Cui collaborates with scholars based in China and United States. Yuan Cui's co-authors include H. Criss Hartzell, Kuai Yu, Jarred M. Whitlock, Eric A. Ortlund, Zhi Qu, Criss Hartzell, Ping Liang, Jian Yang, Qifan Li and Zhike Chen and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and Frontiers in Immunology.

In The Last Decade

Yuan Cui

10 papers receiving 326 citations

Peers

Yuan Cui
Sylwia Jones United Kingdom
Elena McBeath United States
Mark Strobeck United States
S. Okubo Japan
Tomasz Zygmunt United States
David Novo United States
Sylwia Jones United Kingdom
Yuan Cui
Citations per year, relative to Yuan Cui Yuan Cui (= 1×) peers Sylwia Jones

Countries citing papers authored by Yuan Cui

Since Specialization
Citations

This map shows the geographic impact of Yuan Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuan Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuan Cui more than expected).

Fields of papers citing papers by Yuan Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuan Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuan Cui. The network helps show where Yuan Cui may publish in the future.

Co-authorship network of co-authors of Yuan Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Yuan Cui. A scholar is included among the top collaborators of Yuan Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuan Cui. Yuan Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Chen, Jun, Yuan Cui, Chang Li, et al.. (2025). Aberrant Expression of JAM2 Inhibits Invasion and Migration in Lung Adenocarcinoma. Cancer Reports. 8(1). e70038–e70038.
2.
Lu, Xiaoning, Jun Chen, Guang Han, et al.. (2025). FOXM1 Promotes Non-Small Cell Lung Cancer Progression by Increasing CHEK1 Expression. Current Medical Science. 45(3). 525–538.
3.
Zeng, Weibiao, Jin Wang, Jian Yang, et al.. (2023). Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma. Frontiers in Immunology. 14. 1217590–1217590. 11 indexed citations
4.
Tang, Yu, Qifan Li, Dao-Qi Zhang, et al.. (2022). Cuproptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of early-stage lung adenocarcinoma patients. Frontiers in Genetics. 13. 977156–977156. 6 indexed citations
5.
Cui, Yuan, Zhike Chen, Bin Pan, et al.. (2022). Neddylation pattern indicates tumor microenvironment characterization and predicts prognosis in lung adenocarcinoma. Frontiers in Cell and Developmental Biology. 10. 979262–979262. 6 indexed citations
6.
Yang, Jian, Zhike Chen, Qifan Li, et al.. (2022). Immune Landscape and Classification in Lung Adenocarcinoma Based on a Novel Cell Cycle Checkpoints Related Signature for Predicting Prognosis and Therapeutic Response. Frontiers in Genetics. 13. 908104–908104. 7 indexed citations
7.
Ding, Hao, Yuxin Wang, Yuan Cui, et al.. (2022). Comprehensive analysis of the expression and prognosis for RBR E3 ubiquitin ligases in lung adenocarcinoma. Thoracic Cancer. 13(17). 2459–2472. 5 indexed citations
8.
Cui, Yuan, et al.. (2021). ANO5 ensures trafficking of annexins in wounded myofibers. The Journal of Cell Biology. 220(3). 36 indexed citations
9.
Whitlock, Jarred M., Kuai Yu, Yuan Cui, & H. Criss Hartzell. (2018). Anoctamin 5/TMEM16E facilitates muscle precursor cell fusion. The Journal of General Physiology. 150(11). 1498–1509. 61 indexed citations
10.
Yu, Kuai, et al.. (2015). Identification of a lipid scrambling domain in ANO6/TMEM16F. eLife. 4. e06901–e06901. 145 indexed citations
11.
Cui, Yuan, et al.. (2008). Enhanced Trafficking of Tetrameric Kv4.3 Channels by KChIP1 Clamping. Neurochemical Research. 33(10). 2078–2084. 18 indexed citations
12.
Qu, Zhi, et al.. (2007). Activation of Bestrophin Cl– Channels Is Regulated by C-terminal Domains. Journal of Biological Chemistry. 282(24). 17460–17467. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026